title: Gastrin and the enterochromaffin-like cell: an acid update.
abstract: Gastrin is synthesized and secreted mostly in a heptadecapeptide form from neurocrine G cells located in the antrum. The biologically active sequence of the molecule is a C-terminal pentapeptide, which has been conserved across many species. Transcriptional regulation of gastrin mRNA synthesis is positively regulated by transforming growth factor-alpha (TGF-alpha) and inhibited by somatostatin (SST). The inactive precursor form is converted to the active molecule by several post-translation processing steps which include cleavage, C-terminal amidation, glycosylation, phosphorylation and sulfation. Aberrations in processing steps generate incompletely processed forms, particularly glycosylated progastrin, which may act as autocrine growth factors for gastrointestinal neoplasms. Gastrin release is stimulated by luminal aromatic amino acids and inhibited by a decrease in luminal pH. Other gastrin agonists include beta-adrenergic agents, acetylcholine, gastrin-releasing peptide (bombesin), TGF-alpha, and possibly the gastric pathogen, Helicobacter pylori. The principal peptide inhibitor of gastrin release is SST. The major physiological roles of gastrin include stimulation of acid secretion, regulation of mucosal cell lineage and mucosal cell proliferation. The fundic enterochromaffin-like (ECL) cell is the principal cellular transducer of the gastrin-acid signal. Activation of its gastrin/CCKB receptor results in histamine synthesis and release with consequent activation of the fundic parietal cell H2 receptor. An increase in luminal pH caused by acid inhibitory pharmacotherapy agents (particularly proton pump inhibitors) results in hypergastrinemia and ECL cell hyperplasia. Gastric carcinoids however appear occur in patients with multiple endocrine neoplasia type I syndrome, suggesting that an associated genomic defect is necessary. Gastrin is thus both a potent gastrointestinal trophic and histamine secretory agent. As a hormone it is a paradigm in the elucidation of both cellular secretory and growth factor induced cell proliferation.
authors.affiliation: Gastric Surgical Pathobiology Research Group, Yale University School of Medicine, New Haven, CT 06520-8062, USA.
authors.forename: M
authors.initials: M
authors.lastname: Kidd
authors.forename: I M
authors.initials: IM
authors.lastname: Modlin
authors.forename: L H
authors.initials: LH
authors.lastname: Tang
mesh_terms: D019861:Enterochromaffin-like Cells / Q000378:metabolism / Q000502:physiology*; D005744:Gastric Acid / Q000378:metabolism; D019863:Gastrin-Secreting Cells / Q000502:physiology; D005755:Gastrins / Q000096:biosynthesis / Q000502:physiology*; D006801:Humans; D018761:Multiple Endocrine Neoplasia Type 1 / Q000503:physiopathology
chemical_list: D005755:Gastrins